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Abstract 
BACKGROUND: Oxidative stress may play a role in complications of hemodialysis patients as atherosclerosis, 
thrombosis, and inflammation.  
AIM: The aim of the study was to evaluate the oxidative stress in hemodialysis pediatric patients through 
measurement of oxidative stress enzymes as paraoxanase activity (PON), arylesterase activity (ASA), superoxide 
dismutase (SOD) and also non-enzymatic antioxidant vitamins as vitamins A, C and E levels.  
METHODS: The study included 50 hemodialysis pediatric patients with mean age 11.4 ± 5.4 years and 30 normal 
children of matched sex and age as a control group. Assessment of oxidative stresses was done using ELIZA 
technique. 
RESULTS: SOD, ASA, and vitamin C were significantly lower among hemodialysis patients in comparison to 
control group (p = 0.004, 0.004, > 0.001 respectively). 
CONCLUSION: The study concluded that oxidative stress was common finding in hemodialysis pediatric patients 
which may play a role in complications encountered among these patients. 
 
 
 
 
 
 
 
 
Introduction 
 
The global prevalence of chronic renal failure is 
on the rise in pediatric age group. It constitutes one of 
the major causes of death. It is associated with 
oxidative stress which is a significant factor in children 
suffering from renal failure and it may be partly 
responsible for complications of the disease as 
hypertension, anemia, atherosclerosis and related 
cardiovascular disturbances, neurological disorders, 
impaired immunity, and hemostatic abnormalities [1], 
[2], [3], [4], [5]. 
Oxidative stress is defined as tissue damage 
resulting from an imbalance between excessive 
production of free oxygen radical and oxygen 
scavenger which are responsible for antioxidant 
activity [6]. The excess generation of reactive oxygen 
species may be partially due to activation of peripheral 
polymorphonuclear leucocytes interacting with 
dialyzer artificial membrane [7]. The ability of cells to 
scavenge excess reactive species is largely 
dependent on the efficiency of the overall antioxidant 
defense system. The antioxidant defense network 
consists of endogenous and exogenous antioxidants. 
The endogenous antioxidants comprise the enzymatic 
antioxidants such as superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPx) and 
non-enzymatic antioxidants including glutathione 
(GSH), vitamins A, C and E as well as small 
molecules. The exogenous antioxidants comprise the 
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micronutrients and other exogenously administered 
antioxidants [8], [9]. 
Malonyldialdehyde (MDA) is one of the end 
products of polyunsaturated fatty acid peroxidation in 
cells which was repetitively measured in many 
studies, while vitamin E is a major antioxidant in 
biological systems and acts as a powerful chain-
breaking agent because of its ability to scavenge 
peroxyl radicals. An increase in free radicals causes 
an overproduction of MDA, which is a marker of 
oxidative stress, and a reduction in plasma vitamin E 
levels, which may contribute to the development of 
oxidative stress conditions. Vitamin E is mainly 
transported by lipoproteins in the bloodstream. The 
vitamin E/cholesterol ratio indicates how much vitamin 
E can be delivered to cell membranes via the LDL 
receptor [10]. SOD catalyzes dismutation of 
superoxide to hydrogen peroxide. Hydrogen peroxide, 
in turn, is converted to water and molecular oxygen by 
catalase or glutathione peroxidase (GPx) which uses 
glutathione as a substrate [11]. 
The oxidation of low-density lipoproteins 
(LDL) due to oxidative stress conditions is one of the 
first steps in the atherosclerotic process. Oxidized 
LDL initiates an inflammatory reaction that ultimately 
leads to the formation of atherosclerotic plaques. 
High-density lipoproteins (HDL) have long been 
known to be antiatherogenic, but their exact 
mechanism of action has yet to be determined. 
Paraoxonase 1 (PON1), an enzyme associated with 
HDL, is thought to play a crucial role in the anti-
oxidative properties of HDL [12]. 
Unfortunately, studies of oxidative stress in 
children had limited sample sizes and not enough 
convincing evidence to prove the causal relation 
between oxidative stress and disease conditions. 
The aim of the study was to evaluate the 
oxidative stress in hemodialysis pediatric patients 
through measurement of oxidative stress enzymes as 
Paraoxanase activity (PON), Arylesterase activity 
(ASA), superoxide dismutase (SOD) and also non-
enzymatic antioxidant vitamins as vitamins A, C and E 
levels. 
 
 
Patients and Methods 
 
The study included 50 pediatric patients who 
had been treated by conventional regular bicarbonate 
hemodialysis three times weekly using polysulfone 
filter and Fresenius 4008 dialysis system (Fresenius 
Medical Care, Hesse, Germany). Thirty normal 
children of matched age and sex served as a control 
group were collected from outpatient’s clinic. The 
hemodialysis patients were recruited from the 
hemodialysis unit of the Centre of Pediatric 
Nephrology and Transplantation, in Cairo University 
Children Hospital. The studied patients consisted of 
24 (48%) females and 26 (52%) males. The mean age 
of the study population was 11.4 ± 5.4 (4 -20) years 
for hemodialysis patients. Patients with evidence of 
infections, inflammation or malignancy were excluded. 
This study protocol and the consents were 
approved and deemed sufficient by the Ethical 
Committee of  National research Centre and informed 
written consent was obtained in every case from their 
legal guardians. 
All patients were subjected to full history 
taking, thorough clinical examination, and laboratory 
investigations including routine investigations as urine 
analysis, complete blood picture, blood urea nitrogen, 
creatinine, serum sodium, potassium, calcium, 
phosphorus, alkaline phosphatase, SGOT, and SGPT. 
Special tests for assessment of oxidative 
stresss were done including: enzymatic antioxidants 
as Paraoxanase activity (PON), Arylesterase activity 
(ASA), superoxide dismutase (SOD) and non-
enzymatic antioxidant as serum vitamins A, C and E 
levels for hemodialysis and control groups. All of them 
were measured using ELIZA double antibody 
sandwich technique with the commercial available kits 
from Glory Science Co., Ltd (Add: 2400 Veterans 
Blvd. Suite 16-101, Del Rio, TX78840, USA). With 
catalog #: A16846 (ASA), #: 11086 (SOD), #: 90081 
(vitamin C), #: 11345 (vitamin A), #: 11344 (vitamin 
E), #: 95462 (PON1). 
 
Statistical Analysis 
Standard computer program SPSS for 
Windows, release 13.0 (SPSS Inc., USA) was used 
for data entry and analysis. All numeric variables were 
expressed as mean ± standard deviation (SD). 
Comparison of different variables in various groups 
was done using Student t test. Pearson's correlation 
tests (r = correlation coefficient) were used for 
correlating numerical variables. For all tests, a 
probability (P) less than 0.05 are considered 
significant. 
 
 
Results 
 
At the time of the study, the mean dialytic time 
was 55.5 ± 42.64 months (6-180). Descriptive data of 
studied hemodialysis pediatric patients were 
represented in (Table 1). 
The comparison between hemodialysis and 
control group as regard oxidative enzymes and 
antioxidant vitamins revealed decreased all oxidative 
enzymes in hemodialysis group than healthy subjects 
where SOD and ASA were highly significantly reduced 
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while PON was not significantly reduced (p = 0.004, 
0.004, 0.092) respectively (Table 2).  
Table 1: Descriptive data, hematological and biochemical 
results of patients under study 
Parameters Hemodialysis patients 
Age in years 11.4 ± 5.4 (4-20) 
Sex 26 males & 24 females 
Duration of dialysis (months) 55.5 ± 42.64 (6-180) 
Dry weight (kg) 24.2 ± 9.8 
Ultrafiltration (ml) 1573.3 ± 871.6 
Fractional Shorting (FS) 33.4 ± 7.1 
Blood Pressure 
Systolic (mmHg) 
Diastolic (mmHg) 
 
128.2 ± 20.4 
82.8 ± 14.4 
Electrolytes (mEq/l) 
Na predialysis 
Na postdialysis 
K predialysis 
K postdialysis 
 
130.2 ± 5 
135.8 ± 6.1 
7.1 ± 0.6 
3.8 ± 0.5 
Minerals 
Ca (mg/dl) 
P (mg/dl) 
Alkaline phosphatase (IU/L) 
Albumin (gm/dl) 
 
8.8 ± 1.2 
4.6 ± 2 
632.4 ± 488 
3.7 ± 0.5 
Complete Blood Picture 
Hb (g/dl) 
RBCs (10
6
/μL ) 
WBCs (10
3
/μL) 
Platelets (10
3
/μL) 
 
10.1 ±1.5 
3.6 ± 0.5 
5.9 ± 2.4 
197 ± 82.9 
Kidney function (mg/dl) 
Creatinine predialysis 
Creatinine postdialysis 
Creatinine improvement 
Urea predialysis 
Urea postdialysis 
Urea improvement 
 
8.7 ± 3.5 
3.2 ± 1.5 
63.1 ± 15.5 
112 ± 45.7 
21.7 ± 11.3 
79.3 ± 10.3 
Liver function 
SGOT (U/L) 
SGPT (U/L) 
 
21.7 ± 14 
24.8 ± 22 
Data are represented as mean ± sd (range) and as frequency. 
 
As regard antioxidant vitamins, vitamin C was 
significantly reduced in hemodialysis group while 
vitamins A and E were not significantly affected (p = > 
0.001, 0.163, 0.817) respectively (Table 2). 
Table 2: Comparison between hemodialysis and control as 
regard oxidative stress 
 
Hemodialysis 
group 
(50 patients) 
Control group 
(30 patients) 
t-test 
t- value p-value 
Enzymatic Oxidative Stress 
Arylesterase Activity (ASA) 
(ng/ml) 
Superoxide Dismutase (SOD) 
(mU/L) 
 Paraoxanase Activity (PON) 
(nmol/L)  
 
 
12.54 ± 18.98 
 
41.5 ± 42.99 
 
126.83 ± 250.09 
 
 
26.45 ± 22.439 
 
159.8 ± 205.36 
 
232.68 ± 296.52 
 
 
-2.962 
 
-3.114 
 
-1.708 
 
 
0.004 
 
0.004 
 
0.092 
Non Enzymatic Oxidative Stress 
 Vitamin A (nmol/L) 
 Vitamin C (ng/L) 
 Vitamin E (nmol/L) 
 
427.52 ± 798.58 
1342.23 ± 1390.12 
373.79 ± 1017.44 
 
205.39 ± 603.27 
2085.83 ± 465.52 
327.91 ± 478.55 
 
1.408 
-3.905 
0.232 
 
0.163 
< 0.001 
0.817 
 
In hemodialysis group, the correlation 
between oxidative enzymes, antioxidant vitamins and 
different parameters revealed positive correlation 
between vitamin A and age (r = 0.374, P = 0.007).  
Table 3: Correlation between studied oxidative stress 
parameters 
  Vit A Vit C Vit E PON SOD ASA 
Vitamin A 
r 
p 
 
- 0.115 
0.428 
- 0.124 
0.390 
- 0.111 
0.444 
- 0.067 
0.644 
0.198 
0.169 
Vitamin C 
r 
p 
- 0.115 
0.428 
 
0.275 
0.053 
0.554** 
0.000 
0.389** 
0.005 
0.100 
0.491 
Vitamin E 
r 
p 
- 0.124 
0.390 
0.275 
0.053 
 
0.295* 
0.037 
0.545** 
0.000 
0.154 
0.284 
Paraoxanase 
Activity (PON) 
r 
p 
- 0.111 
0.444 
0.554** 
0.000 
0.295* 
0.037 
 
0.410** 
0.003 
- 0.028 
0.849 
Superoxide 
Dismutase (SOD) 
r 
p 
- 0.067 
0.644 
0.389** 
0.005 
0.545** 
0.000 
0.410** 
0.003 
 
0.397** 
0.004 
Arylesterase 
Activity (ASA) 
r 
p 
0.198 
0.169 
0.100 
0.491 
0.154 
0.284 
- 0.028 
0.849 
0.397** 
0.004 
 
r = correlation coefficient P = P Value * P < 0.05 Significant, P < 0.005 highly significant. 
 
SOD was positively correlated with vitamin C 
(r = 0.389 p = 0.005), vitamin E (r = 0.545, P= 0.000), 
PON (r =0.410 P = 0.003), ASA (r = 0.397, P= 0.004), 
and Ca (r = 0.361 P = 0.01). PON was also positively 
correlated vitamin C (r = 0.554, P = 0.000), vitamin E 
(r = 0.295 P = 0.037), predialysis urea level (r = 0.298, 
P = 0.036), Ca (r = 0.361, P = 0.01) (Table 3 and 
Table 4).  
Table 4: Correlation between studied oxidative stress 
parameters and clinical and laboratory findings 
  Age Dur Sys BP Dia BP Urea Creat Ca Alb Kt/v 
Vit A r 
p 
- 0.374** 
0.007 
- 0.059 
0.685 
- 0.022 
0.881 
- 0.159 
0.272 
- 0.166 
0.249 
- 0.055 
0.704 
0.246 
0.085 
0.078 
0.590 
- 0.038 
0.792 
Vit C r 
p 
- 0.105 
0.468 
0.227 
0.113 
- 0.244 
0.087 
- 0.198 
0.167 
0.120 
0.408 
- 0.071 
0.626 
0.168 
0.244 
0.049 
0.734 
- 0.003 
0.981 
Vit E r 
p 
0.076 
0.598 
- 0.135 
0.348 
0.041 
0.775 
0.132 
0.362 
0.072 
0.619 
0.033 
0.820 
0.153 
0.288 
- 0.026 
0.858 
0.000 
0.999 
PON r 
p 
0.009 
0.951 
- 0.022 
0.880 
- 0.026 
0.859 
0.103 
0.476 
0.298* 
0.036 
0.132 
0.361 
0.361** 
0.010 
0.277 
0.052 
- 0.024 
0.868 
SOD r 
p 
0.100 
0.492 
0.104 
0.471 
0.089 
0.538 
0.187 
0.194 
0.066 
0.649 
0.063 
0.666 
0.361* 
0.010 
0.224 
0.117 
0.088 
0.543 
ASA r 
p 
- 0.150 
0.298 
- 0.163 
0.258 
0.067 
0.642 
0.076 
0.598 
- 0.215 
0.134 
- 0.106 
0.463 
0.057 
0.693 
0.050 
0.730 
0.023 
0.873 
Duration of dialysis; Sys BP: Systolic blood pressure; Dia BP: diastolic blood pressure; Creat: 
Creatinine; Ca: Calcium; Alb: Albumin; Dur: after duration of Dialysis. 
 
 
 
Discussion 
 
Hemodialysis in addition to uremia is 
characterized by excessive oxidative stress which is 
due to loss of antioxidants as vitamins C and E, 
accumulation of oxidative product. During 
hemodialysis, activation of complement factors, 
platelets, and polymorphonuclear leucocytes are 
triggered by dialyzer membrane and dialysate and 
subsequently reactive oxygen species production. 
Also inflammatory state and lipid peroxidation, which 
occurred in hemodialysis, promote formation of 
oxidative products. Oxidative stress is also triggered 
by iron infusion, anemia, central venous catheter, 
bioincompatible dialyzers, and endotoxin challenge 
[13], [14]. 
In this study, alteration of oxidative stress and 
antioxidant activity has been demonstrated among 
hemodialysis pediatric patients in comparison to 
control. Antioxidant defense mechanisms have been 
observed including decreased all studied enzymatic 
antioxidant while vitamin C is the only affected among 
non-enzymatic antioxidant vitamins in hemodialysis 
group in comparison to healthy control subjects where 
only SOD, ASA, and vitamin C were highly reduced in 
significant manner. 
Superoxide dismutase represents a major 
defense system against oxidative damage by 
enzymatically converting O2 to H2O2. Zwołińska (2006) 
study on 21 hemodialysis pediatric patients found that 
SOD was significantly decreased [15] which is in 
agreement with our study. Similar to our study, SOD 
activity was significantly lower in hemodialysis 
patients whatever children or adults [16], [17], [18], 
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[19], [20], [21], [22]. In contrast to our study, activity of 
SOD has been increased in few studies which were 
explained by invoking adaptation to the increased rate 
of oxidation [23], [24], [25]. In Lim (1999) study, no 
significant difference of Erythrocyte-SOD (E-SOD) 
level was found between hemodialysis and control but 
the plasma level of SOD was increased in 
hemodialysis in comparison to control [26]. 
Paraoxonase (PON) is another marker of 
antioxidant activity. It is esterase enzyme associated 
with HDL and functions to protect LDL and HDL from 
oxidation. PON activities are decreased in subjects 
with renal failure with increased risk of cardiovascular 
disease especially the hemodialysis patients which 
had the lowest activity. In contrast to previous studies 
that revealed reduced paraoxonase levels than control 
[27], [28], [29], [30], [31], [32]; our results revealed 
insignificant reduction of PON which was used as a 
marker of antioxidant activity in hemodialysis patients 
in comparison to controls. 
Human arylesterase enzyme is a member of 
the paraoxonase family that has a protective effect 
against lipoprotein oxidation in CKD through 
hydrolysis of organophosphate compounds. Also 
arylesterase displays Hcy-thiolactonase activity and 
poses antiatherogenic properties. Similar to our study, 
few studies reported that ASA decreased in CKD 
patients on hemodialysis when compared to healthy 
controls [28], [33], [34]. 
Vitamin E exerts its effect as antioxidant 
through interruption of the radical cascade to protect 
cell membranes from lipid peroxidation by forming a 
low-reactivity vitamin that attack lipid substrate. 
Vitamin E can protect the cell membrane against free 
radicals induced oxidative damage by LDL in 
biological membranes [35]. In this study, the vitamin E 
levels were insignificantly increased. Similar to our 
study, Nguyen-Khoa (2001) study showed that plasma 
vitamin E levels were insignificantly different in 
hemodialysis patients and control subjects [18], while 
in Locatelli et al., (2003) study, the intracellular levels 
of vitamin E were significantly reduced [3]. Also 
Zwolinska et al., (2006) study revealed significant 
reduction of plasma vitamin E levels among 
hemodialysis patients in comparison to control while 
the erythrocyte vitamin E levels of HD pediatric 
patients were not different [36]. The reduced level of 
vitamin E can be explained by reduced dietary intake, 
malnutrition, and loss during hemodialysis. In contrast 
to previous studies, Joyce et al., (2018) study 
revealed that hypervitaminosis E was present in 87% 
of pediatric patients [37]. 
Vitamin C is considered as a potent 
antioxidant in biological fluids and thus prevents 
oxidative damage to important biological 
macromolecules. As regard vitamin C levels, 
Francesco Locatelli and Zwolinska et al., [3], [36] 
studies showed reduced vitamin C levels which 
coincide with our results and can be explained by 
reduced dietary intake of fresh fruits and vegetables to 
avoid hyperkalemia, malnutrition and loss of the 
vitamin during hemodialysis with clearance rate 30%-
53% and losses from 80 to 280 mg per session [3], 
[36], [38], [39].  
 As regard vitamin A level, hypervitaminosis A 
is present in hemodialysis pediatric patients as in CKD 
patients and is associated with hypercalcemia among 
hemodialysis [40]. In Joyce et al., (2018) study, 
hypervitaminosis A was present in 94% of pediatric 
patients [37]. Hypervitaminosis A is explained by 
homeostatic dysregulation of its plasma carrier, the 
retinol binding protein [41]. Only one study done by 
Zwolinska (2006) revealed reduced levels of plasma 
vitamin A [36] but in our study no significant difference 
was found between hemodialysis patients and control. 
The correlation between different parameters 
of this study revealed positive correlation between 
different antioxidant which means that oxidative stress 
may act synergistically to increase cardiovascular 
morbidity and mortality risk in maintenance 
hemodialysis patients. 
There are few limitations to our study findings: 
1. The nutritional data is not collected from our 
patients to assess the amount of vitamins ingestion; 2. 
There is wide range of variability in enzymes and 
vitamins levels. 
The study concluded that oxidative stress was 
common finding in hemodialysis pediatric patients 
who may play a role in complications as 
atherosclerosis and adequate vitamin 
supplementation may be recommended and have 
therapeutic potential. 
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